Nicholas van Buuren

机构：Gilead Sciences (United States) · ORCID：0000-0003-2746-4422

发表论文 36 篇 · 总被引 856 次 · h-index 16

代表论文

• An RNA-centric dissection of host complexes controlling flavivirus infection (2019 · Nature Microbiology · 被引 132)
• Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection (2022 · Journal of Hepatology · 被引 80)
• Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression (2022 · Journal of Hepatology · 被引 61)
• Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection (2021 · JHEP Reports · 被引 52)
• Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo (2022 · Molecular Therapy · 被引 50)
• Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B (2022 · JHEP Reports · 被引 50)